[Studies of the effect of I-adamantyl-amine hydrochloride and of L-dopa with Ro 4-4602 in human catatonia].
D000328:Adult; D000547:Amantadine / Q000627:therapeutic use; D001332:Automatism / Q000188:drug therapy; D001545:Benserazide / Q000627:therapeutic use; D002375:Catalepsy / Q000188:drug therapy; D002389:Catatonia / Q000188:drug therapy*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013239:Stereotyped Behavior / Q000187:drug effects
D004338:Drug Combinations; D006834:Hydrazines; D004295:Dihydroxyphenylalanine; D001545:Benserazide; D000547:Amantadine
Rilievi sull'effetto della I-adamantil-ammina cloridrato e della L-dopa Ro4-4602 nella catatonia umana.